Skip to main content
SpringerLink
Log in

Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings

  • Published:
Journal of Gastrointestinal Surgery

Abstract

The autopsy findings of patients who died of recurrence after curative resection of pancreatic cancer may afford a reliable guide to increase long-term survival after surgery. Recurrence patterns were analyzed for 27 autopsied patients who had undergone potentially curative resection of pancreatic cancer. The pattern of recurrence was classified as follows: (1) local recurrence, (2) hepatic metastasis, (3) peritoneal dissemination, (4) para-aortic lymph node metastasis, and (5) distant metastasis not including hepatic metastasis, peritoneal dissemination, and para-aortic lymph node metastasis. Of the 27 autopsied patients, recurrence was confirmed for 22 of 24 patients, except for three who died of early postoperative complications. Eighteen (75%) of the 24 patients had local recurrence, 12 (50%) had hepatic metastasis, and 11 (46%) had both. For four patients, local recurrence confirmed by autopsy was undetectable by computed tomography, because the recurrent lesions had infiltrated without forming a tumor mass. Peritoneal dissemination, para-aortic lymph node metastasis, and distant metastasis were found for eight (33%), five (21%), and 18 (75%) of the cases, respectively. Twenty patients died of cancer, but local recurrence was judged to be the direct cause of death of only four. Local recurrence frequently occurs, but is rarely a direct cause of death, and most patients died of metastatic disease. Therefore, treatment that focuses on local control cannot improve the survival of patients with resectable pancreatic cancer, and thus, treatment regimens that are effective against systemic metastasis are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Niederhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer. Cancer 1995; 76:1671–1677.

    Article  PubMed  CAS  Google Scholar 

  2. Matsuno S, Egawa S, Fukuyama S, et al. Pancreatic cancer registry in Japan: 20 Years of experience. Pancreas 2004;28:219–230.

    Article  PubMed  Google Scholar 

  3. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J GASTROINTEST SURG 2000;4:567–579.

    Article  PubMed  CAS  Google Scholar 

  4. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-Year survivors. J Am Coll Surg 2004;198:722–731.

    Article  PubMed  Google Scholar 

  5. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-Year experience. World J Surg 2003;27:324–329.

    Article  PubMed  Google Scholar 

  6. Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215–220.

    Article  PubMed  CAS  Google Scholar 

  7. Nagakawa T, Nagamori M, Futakami F, et al. Results of extensive surgery for pancreatic carcinoma. Cancer 1996; 77:640–645.

    Article  PubMed  CAS  Google Scholar 

  8. Hiraoka T, Kanemitsu K. Value of extended resection and intraoperative radiotherapy for resectable pancreatic cancer. World J Surg 1999;23:930–936.

    Article  PubMed  CAS  Google Scholar 

  9. Takahashi S, Ogata Y, Miyazaki H, et al. Aggressive surgery for pancreatic duct cell cancer: Feasibility, validity, limitation. World J Surg 1995;19:653–660.

    Article  PubMed  CAS  Google Scholar 

  10. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2. Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355–368.

    Article  PubMed  Google Scholar 

  11. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Ann Surg 1998;228:508–517.

    Article  PubMed  CAS  Google Scholar 

  12. Kalser MH, Ellenberg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903.

    Article  PubMed  CAS  Google Scholar 

  13. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776–784.

    Article  PubMed  CAS  Google Scholar 

  14. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200–1210.

    Article  PubMed  CAS  Google Scholar 

  15. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006–2010.

    Article  Google Scholar 

  16. Japan Pancreas Society. Classification of Pancreatic Carcinoma, 2nd English ed. Tokyo: Kanehara & Co., Ltd., 2003.

    Google Scholar 

  17. Komaki R, Hansen R, Cox JD, Wilson JF. Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1998;15:1447–1452.

    Google Scholar 

  18. Komaki R, Wadler S, Peters T, et al. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas: A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer 1992;69:2807–2812.

    Article  PubMed  CAS  Google Scholar 

  19. Hishinuma S, Ogata Y, Tomikawa M, et al. J Hepatobiliary Pancreat Surg 2005;12:235–242.

    Article  PubMed  Google Scholar 

  20. Sobin LH, Wittekind C. Prophylactic hepatic irradiation following curative resection of pancreatic cancer. UICC TNM Classification of Malignant Tumours, 6th ed. New York: John Wiley & Sons, Inc., 2002.

    Google Scholar 

  21. Imamura M, Doi R, Imaizumi T, et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 2004; 136:1003–1011.

    Article  PubMed  Google Scholar 

  22. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56–6l.

    Article  PubMed  CAS  Google Scholar 

  23. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118–2123.

    Article  PubMed  CAS  Google Scholar 

  24. Johnstone PA, Sindelar WF. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: Correlations of a clinical trial. Int J Radiat Oncol Biol Phys 1993;27:831–834.

    Article  PubMed  CAS  Google Scholar 

  25. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997;21:195–200.

    Article  PubMed  CAS  Google Scholar 

  26. Fortner JG. Regional pancreatectomy for carcinoma of the pancreas, ampulla, and other related sites: Tumor staging and results. Ann Surg 1984;199:418–425.

    Article  PubMed  CAS  Google Scholar 

  27. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586–594.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Tochigi Cancer Center, 4-9-13, Yohnan, Utsunomiya, 320-0834, Tochigi, Japan

    Shoichi Hishinuma M.D., Yoshiro Ogata M.D., Moriaki Tomikawa M.D. & Iwao Ozawa M.D.

  2. Department of Pathology, Tochigi Cancer Center, Tochigi, Japan

    Kaoru Hirabayashi M.D. & Seiji Igarashi M.D.

Authors
  1. Shoichi Hishinuma M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshiro Ogata M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moriaki Tomikawa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iwao Ozawa M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kaoru Hirabayashi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiji Igarashi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shoichi Hishinuma M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hishinuma, S., Ogata, Y., Tomikawa, M. et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. Journal of Gastrointestinal Surgery 10, 511–518 (2006). https://doi.org/10.1016/j.gassur.2005.09.016

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2005.09.016

Key words

Search

Navigation